Weaver Consulting Group Novo Nordisk A S Transaction History

Weaver Consulting Group

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 29, 2021	SELL	$63.89 - $73.8 $11,755 - $13,579	-184 Closed	0 $0
Q2 2020 Jul 24, 2020	BUY	$58.54 - $67.94 $1,697 - $1,970	29 Added 18.71%	184 $12,000
Q1 2020 Apr 28, 2020	BUY	$49.46 - $64.78 $4,401 - $5,765	89 Added 134.85%	155 $9,000
Q1 2019 Jun 19, 2019	BUY	$46.36 - $52.63 $3,059 - $3,473	66 New	66 $3,000

1,886

335M

11.9M

10.6M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $162B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Weaver Consulting Group, based on Form 13F filings with the SEC.

Stay updated on Weaver Consulting Group with notifications on news.